Skip to main content
Bilal Farhan, MD, Urology, Texas City, TX

BilalFarhanMD

Urology Texas City, TX

Female Urology/Pelvic Medicine & Reconstructive Surgery, Minimally Invasive Surgery, Surgical Oncology, Trauma & Reconstructive Surgery

Assistant Professor in Female Urology, Voiding dysfunction and Pelvic Reconstruction Surgery

Dr. Farhan is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Farhan's full profile

Already have an account?

  • Office

    10121 Emmett F Lowry Expy
    Texas City, TX 77591
    Phone+1 409-986-9686
    Fax+1 409-978-4324

Summary

  • I am fellowship trained Urologist in Voiding dysfunction, female urology, male incontienence at the UC, Irvine. I am Board cerrfied by Arab and Jordanian Medical Board of Urology.
  • Bilal Farhan, MD

    Bilal Farhan, MD is the assistant clinical professor and the medical director of Female Urology, Voiding Dysfunction and Pelvic Reconstruction Program at UTMB H

Education & Training

  • University of California (Irvine)
    University of California (Irvine)Fellowship, Urology, 2016 - 2019
  • University of California (Irvine)
    University of California (Irvine)Fellowship, Female Pelvic Medicine And Reconstructive Surgery (Obgyn), 2016 - 2018
  • Jordan University of Science and Technology FOM
    Jordan University of Science and Technology FOMClass of 2006, Arab Board of Urology;

Certifications & Licensure

  • TX State Medical License
    TX State Medical License 2019 - 2026
  • CA State Medical License
    CA State Medical License 2018 - 2025
  • AOA Board of Surgery Urological Surgery
  • Arab Board of UrologyArab Board of Urology
  • UROLOGYJordanian Board of Urology

Awards, Honors, & Recognition

  • Top Podium MP26-17 URINARY LEVEL OF MONOCYTE CHEMOTACTIC PROTEIN-1 (MCP-1) PREDICTS THE SEVERITY OF SYMPTOM IN PATIENT WITH OVERACTIVE BLADDER (OAB): PILOT PROSPECTIVE STUDY. Society of Urodynamics and Female Urology, 2018

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Unilateral orchiectomy of a testicular adrenal rest tumor: Case report and review of management options  
    Corey Able, Brian Liao, Elias Farran, Abdul Majeed Abid, Bilal Farhan, Urology Case Reports, 9/8/2022
  • Allograft Pubovaginal Slings: a Systematic Review  
    Cynthia Cabrales, Brian Liao, Corey Able, George Coba, Bilal Farhan, Current Bladder Dysfunction Reports, 8/23/2022

Abstracts/Posters

  • MP26-17 URINARY LEVEL OF MONOCYTE CHEMOTACTIC PROTEIN-1 (MCP-1) PREDICTS THE SEVERITY OF SYMPTOM IN PATIENT WITH OVERACTIVE BLADDER (OAB): PILOT PROSPECTIVE STUDY.
    Bilal Farhan, Frank Zaldivar, Gamal Ghoniem, Journal of Urology, AUA2018, 5/10/2018

Press Mentions

  • AUA 2019: Women's Experience with Stress Urinary Incontinence: Insights from a Qualitative Social Media Analysis
    AUA 2019: Women's Experience with Stress Urinary Incontinence: Insights from a Qualitative Social Media AnalysisMay 5th, 2019
  • SUFU 2020: A Community-Based Education Program for Overactive Bladder in Older Adults: A Pilot Study
    SUFU 2020: A Community-Based Education Program for Overactive Bladder in Older Adults: A Pilot StudyMarch 2nd, 2020
  • SUFU 2019: Role of Corticotropin Releasing Hormone in Mouse Micturition Behavior
    SUFU 2019: Role of Corticotropin Releasing Hormone in Mouse Micturition BehaviorFebruary 28th, 2019
  • Join now to see all

Research History

  • Research fellow2014 - 2016

Other Languages

  • Arabic